SUMMARY In view of evidence suggesting an association of mild hypokalaemia with cardiac arrhythmia, the arrhythmogenic potentials of potassium losing and potassium sparing diuretic treatments were compared in a controlled prospective crossover study of 10 patients with mild hypertension and ischaemic heart disease. Mean (SEM) plasma potassium was 4.3(0.06) mmol/l and 3.3(0.07) mmol/l after potassium sparing and potassium losing treatments respectively. Blood pressure and volume depletion as assessed by weight change, plasma renin activity, and noradrenaline concentrations did not differ significantly in the two treatment periods. The potassium losing treatment phase was associated with an increased frequency of ventricular extrasystoles, a higher Lown grading during ambulatory electrocardiographic monitoring, prolonged duration and decreased phase 0 velocity of the monophasic action potential, a prolonged ventricular effective refractory period, and increased myocardial electrical instability as assessed by programmed ventricular stimulation.
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It is concluded that minor changes in plasma potassium concentration are associated with increased ventricular electrical instability in patients with ischaemic heart disease. Mild hypokalaemia in such patients may predispose to life threatening arrhythmias and should be avoided.
Severe hypokalaemia (plasma potassium <3-0 mmolll) is known to be associated with an increased incidence of cardiac arrhythmias. [1] [2] [3] [4] Table 2 . Plasma potassium concentration measured just before the study was 4-15(0-10) mmol/l. The plasma potassium Fig. 1 (a Ambulatony electrocardiography-Because of a tape failure in one study, paired data were obtained in only nine patients. There was a significantly greater (p<0.05) hourly frequency of ventricular extrasystoles and a higher Lown grade (p<0-05) during the potassium losing phase than during the potassium sparing phase (Fig. 1) . In seven of nine studies, the frequency of ventricular extrasystoles was greater during the potassium losing phase (Fig. 1) . The Lown grade was higher in five patients during the potassium losing phase, but in the remaining four cases it was similar during both treatments (Fig. 1) . There was no apparent relation between the frequency of ventricular extrasystoles or Lown grading and plasma potassium concentration.
Exercise testing-Exercise tests were positive in five patients, two on the basis of 1 mm horizontal ST segment depression, and angina developed in three. Right veicular monaphasic achion potential-The slope of the action potential upstroke was significantly (p<0.05) steeper during the potassium sparing phase. Action potential duration at 50% repolarisation was prolonged during the potassium losing phase but this difference was not statistically significant. Action potential duration at 90% repolarisation, however, was significantly prolonged by hypokalaemia (p<0*001) (Fig. 2) .
Right venicudar effective refractory period-The effective refractory period of the right ventricle during the potassium losing phase was significantly prolonged (240 (22) Tachycardia induction studies-One patient developed sustained ventricular tachycardia requiring DC shock during the potassium losing phase. Because he refused to continue in the study he did not complete the potassium sparing phase. Data from the 10 paired studies are shown in Fig. 3 . Four patients developed tachycardia and had higher myocardial electrical instability scores during the potassium losing phase than during potassium sparing phase. In all but one of the remaining patients the scores were the same with both treatment regimens. In one patient the score during the potassium sparing phase was slightly higher than that during the potassium losing phase. Nonsustained ventricular tachycardia was induced in five patients during the potassium losing phase and in three patients during the potassium sparing treatment phase.
Heat rate-Heart rate (mean (SEM)) in the potassium losing phase was 80.0(11*9) beats/min and 79 
HORMONE RESULTS
Hormone values when patients were lying or standing are shown in Fig. 4 . Concentrations in supine patients and the rise in plasma noradrenaline and angiotensin II concentrations with erect posture were comparable in the two treatment phases. Plasma aldosterone, however, was significantly higher during treatment with potassium sparing diuretics (p<0001). Although plasma renin activity was lower in this phase, the difference was not statistically significant.
Discussion
Although severe potassium deficiency may precipitate life threatening cardiac arrhythmias, the effect of less severe hypokalaemia, particularly in patients with ischaemic heart disease, is controversial."I 14 Recent studies have increased concern that conventional potassium losing diuretic treatment may be arrhythmogenic. The Medical Research Council mild hypertension study showed a significantly greater frequency of ventricular extrasystoles in patients treated with thiazide diuretics than in untreated control patients. 27 Others have shown similar changes during thiazide treatment that were partly abolished by potassium repletion. I 12 Observations of an increased incidence of ventricular fibrillation after acute myocardial infarction in hypokalaemic patients28 29 and of increased incidence of sudden death associated with high dose diuretic treatment of patients with mild hypertension5 15 16 add further to the concern. Although there were several explanations for these findings, the possibility of a causal relation between diuretic treatment and increased mortality in certain subgroups of hypertensive patients requires urgent clarification. There are, however, practical problems. To show a causal relation between hypokalaemia and sudden death in a small subgroup of patients requires a very large scale trial. 14 In the absence of this information, the case for preventing diuretic induced hypokalaemia must be based on appropriately designed and controlled electrical trials showing a consistent association of increased myocardial electrical instability with potassium losing treatment.
We have examined prospectively in a randomised crossover controlled trial the effect of two short term diuretic treatments (one associated with potassium sparing and the other associated with potassium loss) in patients with mild essential hypertension and ischaemic heart disease. The hypotensive effect, and the degree of volume depletion as judged by body weight, activity of the renin angiotensin system, and catecholamine concentrations were comparable with the two treatments. There were significant differences 295 between the two treatments in plasma potassium, acid base, chloride and urate concentrations that accorded with the known actions of the diuretics. Plasma aldosterone was significantly higher in the potassium sparing phase as previously reported.30 More importantly, consistent electrophysiological changes occurred in all patients during the potassium losing phase, and there was evidence of increased cardiac electrical instability as measured by several different standardised techniques. While animal and in vitro studies have shown that severe hypokalaemia (plasma potassium <3-0 mmol/l) is associated with increased membrane potential negativity, increased rate of depolarisation, and increased duration of action potential3 1 32 the present study is the first to show that similar changes in action potential occur in man during modest changes in plasma potassium. Prolongation of action potential duration is indicative of delayed repolarisation. There was no significant difference between the two treatment phases at 500/o repolarisation. This measurement includes phase 0, 1, and 2 of the action potential. Significant prolongation of the action potential was evident at 90% repolarisation during the potassium losing phase but not at 50%. This suggests that delayed repolarisation due to moderate hypokalaemia is mainly attributable to prolongation of phase 3 of the action potential. The action potential duration is heart rate dependent but rates during both treatment phases were identical; thus heart rate was not a factor responsible for the difference in delayed repolarisation in the potassium losing phase. Delayed repolarisation is usually estimated from the QT interval of the surface electrocardiogram. This is a measurement which is imprecise since it is often difficult to define the start and end of the QT segment in the surface electrocardiogram. There is no universal agreement on the choice of lead from which this measurement is to be made. In contrast to this the monophasic action potential can define the phases of excitation and repolarisation with a high degree of precision.33 These factors probably explain why we found more consistent and significant changes in the potassium losing phase from analysis of the monophasic action potential than from the QT segment measurement. A generalised electrophysiological effect of the potassium losing treatment is supported by lengthening of the effective refractory period of the right ventricle in every patient. 1 27 Exercise induced ventricular extrasystoles occurred in only two of 20 studies and both patients were taking a potassium losing diuretic. This low frequency of ventricular extrasystoles during exercise (compared with that seen during ambulatory monitoring) is similar to previous reports. "I Although these results are consistent with increases in cardiac electrical instability associated with the potassium losing treatment, it is doubtful whether such findings alone constitute proof of increased susceptibility to life threatening arrhythmias.3738 We therefore sought additional information by inducing tachycardia by programmed intracardiac stimulation-a technique which is regarded as a reliable predictor of serious arrhythmias.39-41 The electrical stability of the myocardium was assessed in two ways. Firstly, the frequency of induced ventricular tachycardia was measured, and secondly, we used a scoring system that takes into account both the number of repetitive responses as well as the number of stimuli required. Non-sustained ventricular tachycardia developed in five patients during the potassium losing phase and in three patients during the potassium sparing phase. In most patients the electrical instability score was similar for both diuretic treatments; thus overall there was no statistical difference between scores from the two phases of treatment. In those patients in whom there was a change (increase or decrease in score) electrical instability increased in four and decreased slightly in only one patient during the potassium losing phase of treatment.
While our observations of increased myocardial electrical instability may be explicable on the basis of potassium depletion, other factors could be involved. In keeping with previous reports" I we found no correlation between plasma potassium concentration and indices of cardiac electrical instability. Despite the suggested importance of magnesium42 there were no significant differences in plasma magnesium between the two treatment phases. The possibility of diuretic induced hormonal changes, particularly in noradrenaline, contributing to increased electrical instability was investigated, with negative results. Further research is needed to evaluate the contribution of factors other than potassium.
As recently emphasised, no single technique is yet available to identify patients at high risk of sudden cardiac death.43 Our study has examined myocardial electrical function in several ways and is not depenStewart, Ikram,, Espiner, Nicholls dent on a single technique for its conclusions. The results show that diuretic induced changes in plasma potassium are associated with demonstrable electrophysiological changes in all patients, that most showed increased frequency and complexity of ventricular extrasystoles, and that some had exercise induced arrhythmias. A smaller number were more susceptible to ventricular arrhythmias elicited by intracardiac stimulation. These findings, obtained in a small number of carefully studied patients, seem to reflect the clinical situation in which most patients may well have electrophysiological changes, but only a small proportion have major or fatal arrhythiias. It should be noted that our patients were not a high risk group; none had extensive coronary artery disease, history of significant arrhythmia, cardiac failure, or use of digitalis or other cardioexcitatory drugs. Since it is easier to prevent potassium deficiency than to treat it, 44 we conclude that a reduction in plasma potassium should be avoided in patients with ischaemic heart disease requiring diuretics.
